BMS-247243

structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Bonner, Daniel P: 1 article (04/2002)
2.	Chaniewski, Susan: 1 article (04/2002)
3.	Clark, Junius: 1 article (04/2002)
4.	Ferraro, Cheryl: 1 article (04/2002)
5.	Fung-Tomc, Joan C: 1 article (04/2002)
6.	Gradelski, Elizabeth: 1 article (04/2002)
7.	Huczko, Elizabeth: 1 article (04/2002)
8.	Kolek, Benjamin: 1 article (04/2002)
9.	Lamb, Lucinda: 1 article (04/2002)
10.	Medina, Ivette: 1 article (04/2002)

1.	Infections 04/01/2002 - "In conclusion, BMS-247243 has in vitro and in vivo activities against methicillin-resistant staphylococci and thus may prove to be useful in the treatment of infections caused by these multidrug-resistant organisms." 04/01/2002 - "These in vitro activities of BMS-247243 correlated with its in vivo efficacy against infections in animals, including the neutropenic murine thigh and rabbit endocarditis models involving MRSA strains. "
2.	Endocarditis 04/01/2002 - "These in vitro activities of BMS-247243 correlated with its in vivo efficacy against infections in animals, including the neutropenic murine thigh and rabbit endocarditis models involving MRSA strains. "